A previous study indicated that deoxygedunin, as a small molecule TrkB agonist, improved the behavioral performance of PD model mice and reduced dopaminergic neuron loss in the SN, displaying prominent neuroprotective properties (Nie et al. 2015). Here, NTRK2 is linked to Parkinson disease.